In order to prevent spam,
this email address cannot be copied.
Researcher Profile - Carlos A. Saura Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Community: Researcher Profiles
Researcher Profile

RESEARCHER INFORMATION
First Name:Carlos A.
Last Name:Saura
Title:Research Assistant Professor
Advanced Degrees:PhD
Affiliation:Universitat Autonoma Barcelona
Department:Institut of Neuroscience
Street Address 1:Edifici M, M2-118
City:Bellaterra (Cerdanyola Valles)
State/Province:Barcelona
Zip/Postal Code:08193
Country/Territory:Spain
Phone:34-935814827
Fax:34 935814152
Email Address: 
Disclosure:
(view policy) 
Member reports no financial or other potential conflicts of interest. [Last Modified: 24 May 2004]
View all comments by Carlos A. Saura
Clinical Interests:
Alzheimer Disease
Research Focus:
A-beta PP/A-beta, Animal Models, Neuropathology, Neurobiology, Signal transduction
Work Sector(s):
University
Web Sites:
Professional: www.uab.es
Researcher Bio
1988-1993 B.S. University of Barcelona, Spain (Chemistry)
1993-1995 Master University of Barcelona, Spain (Biochemistry)
1995-1998 Ph.D University of Barcelona, Spain (Chemistry)

Postdoctoral Training and Current Position:

1998-1999 Postdoctoral Fellow, Department of Pathology, Johns Hopkins University

1999-2000 Postdoctoral Fellow, Department Neurobiology, Pharmacology & Physiology, University of Chicago

2000-2002 Research Fellow, Department of Neurology,
Harvard Medical School

2002- 2004 Instructor in Neurology, Department of Neurology, Harvard Medical School

2004- Research Assistant Professor, Institut of Neuroscience, Universitat Autonoma Barcelona, Spain
Top Papers
1.Saura, C. A.et al. Loss of Presenilin function causes impairments of memory and synaptic plasticity followed by age-dependent neurodegeneration. Neuron 42 (1):23-36 (2004)

2.Gines,S., Ivanova,E., Seong,I-S, Saura,C.A and MacDonald, M. .E. Enhanced Akt signaling is an early pro-survival response that reflects N-Methyl-D-aspartate receptor activation in Huntington’s disease knock-in striatal cells. J.Biol. Chem. 278(50):50514-50522 (2003)

3. Yu, H.* et al. APP processing and synaptic plasticity in Presenilin-1 conditional knockout mice. Neuron, 2001; 31 (5): 713-726.

4. Leem, J.Y.et al A role of presenilin 1 in regulating the delivery of amyloid precursor protein to the cell surface. Neurobiol. Dis., 2002; 11 (1): 64-82.

5. Saura, C.A. et al. The non-conserved hydrophilic loop domain of presenilin (PS) is not required for PS endoproteolysis or enhanced Ab42 production mediated by familial early-onset Alzheimer’s disease-linked PS variants. J. Biol. Chem. 2000; 275 (22): 17136-17142

6.Saura, C.A., et al Evidence that intramolecular associations between Presenilin domains are obligatory for endoproteolytic processing. J. Biol. Chem. 1999; 274 (20): 13818-13823.

7. Saura, C. A. et al Adenosine deaminase and A1 adenosine receptors internalize together following agonist-induced receptor desensitization. J. Biol. Chem. 1998; 273 (28): 17610-17617.
What is the greatest void to date in our knowledge of Alzheimer's Disease?
Early causes of memory dysfunction in AD
What are the top three papers (not yours) you have read recently?

PNAS 2004; 101: 7141-7146
PNAS 2004; 101:8162-8167

Ann Neurol 2004; 55:617-626
If resources were not limited, what research projects would you pursue?
Therapy using AD animal models
What is your leading hypothesis?
Synaptic and memory impairments are early events in AD. Presenilin dysfunction cause FAD by Ab-dependent and independet mechanisms.
What piece of missing evidence would help prove it?
Early synaptic dysfunction is an early event in AD.

Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad